OpenSAFELY Vaccine Coverage Report

First dose / Priority Group 5

Data from combined, up to 2021-03-07.

Vaccinated at 2021-03-07 (%) Vaccinated at 2021-03-07 (n) Population Vaccinated at 2021-02-28 (%) Vaccinated in past week (%)
Overall - 86.5% 2,135,686 2,469,026 83.1% 3.4%
Sex Female 87.3% 1,099,959 1,259,475 84.0% 3.4%
Male 85.6% 1,035,727 1,209,551 82.3% 3.4%
Ethnicity White - British 90.5% 1,308,118 1,445,248 87.2% 3.3%
White - Irish 84.8% 13,202 15,568 82.2% 2.6%
White - Any other White background 63.8% 50,470 79,128 61.2% 2.6%
Mixed - White and Black Caribbean 61.7% 1,953 3,164 58.2% 3.5%
Mixed - White and Black African 62.4% 1,603 2,569 59.4% 3.0%
Mixed - White and Asian 79.7% 2,030 2,548 76.9% 2.7%
Mixed - Any other mixed background 71.8% 3,535 4,921 68.6% 3.3%
Asian or Asian British - Indian 84.9% 42,616 50,218 82.8% 2.1%
Asian or Asian British - Pakistani 67.4% 16,842 24,983 64.0% 3.4%
Asian or Asian British - Bangladeshi 77.1% 4,760 6,174 72.8% 4.3%
Asian or Asian British - Any other Asian background 78.4% 17,556 22,407 75.7% 2.7%
Black or Black British - Caribbean 53.5% 7,987 14,924 50.0% 3.6%
Black or Black British - African 56.8% 8,645 15,211 53.0% 3.9%
Black or Black British - Any other Black background 59.9% 2,177 3,633 56.1% 3.9%
Other ethnic groups - Chinese 68.2% 6,398 9,380 64.6% 3.6%
Other ethnic groups - Any other ethnic group 65.0% 8,589 13,216 62.1% 2.9%
Patients with any other ethnicity code 87.2% 284,935 326,662 83.6% 3.7%
Ethnicity not stated 80.0% 12,103 15,120 76.5% 3.6%
Ethnicity not recorded 82.7% 342,055 413,847 78.8% 3.9%
Ethnicity (broad categories) White 89.1% 1,371,804 1,539,958 85.9% 3.2%
Mixed 69.2% 9,142 13,209 66.1% 3.1%
South Asian 78.8% 81,802 103,796 76.1% 2.7%
Black 55.7% 18,823 33,782 51.9% 3.8%
Other 66.3% 14,987 22,610 63.1% 3.2%
Unknown 84.6% 639,100 755,650 80.8% 3.8%
Index of Multiple Deprivation 1 (most deprived) 83.4% 641,865 769,692 79.9% 3.5%
2 83.1% 295,211 355,047 79.1% 4.1%
3 87.1% 370,811 425,523 83.5% 3.6%
4 89.4% 399,357 446,950 86.2% 3.1%
5 (least deprived) 91.0% 409,864 450,282 88.4% 2.6%
Unknown 86.3% 18,564 21,518 81.2% 5.1%
Clinical Risk Groups Patients in Any Clinical Risk Group 88.2% 796,327 902,923 84.8% 3.4%
Patients with Immunosuppression 90.3% 33,915 37,541 87.2% 3.1%
Patients with CKD 89.4% 103,719 115,997 86.2% 3.2%
Patients who have Chronic Respiratory Disease 87.9% 84,784 96,425 84.4% 3.5%
Patients with Diabetes 87.8% 284,928 324,366 84.5% 3.3%
Patients with Chronic Liver disease 87.4% 64,064 73,311 84.1% 3.3%
Patients with CNS Disease (including Stroke/TIA) 87.8% 118,286 134,673 84.0% 3.8%
Patients with Chronic heart disease 89.1% 333,130 374,017 85.7% 3.3%
Patients with Asplenia or Dysfunction of the Spleen 91.1% 12,887 14,140 88.0% 3.2%
Patients with Wider Learning Disability 76.8% 4,452 5,796 68.8% 8.0%
Patients with Severe Mental Health 74.9% 17,731 23,688 70.1% 4.8%
Other Groups Patients with Morbid Obesity 87.2% 67,893 77,875 83.4% 3.8%
Patients who are pregnant 88.9% 224 252 83.3% 5.6%